Introduction
Transcranial magnetic stimulation (TMS) has become an important diagnostic tool for evaluating the degree of cortical excitability in human brain.
Repetitive TMS (rTMS) can be used to modulate cortical excitability, and several therapeutic trials have demonstrated its clinical efficacy in movement disorders such as Parkinson's disease 1 and writer's cramp. 2 In the field of clinical epileptology, several studies have suggested therapeutic use of rTMS and electric cortical stimulation for seizure control. [3] [4] [5] [6] [7] [8] Despite a potential risk to activate epileptic focus by TMS, 9 the safety of low-frequency rTMS has already been established, 10, 11 and reduction of Seizure (2005) Summary We evaluated the effect of low-frequency repetitive transcranial magnetic stimulation (rTMS) on seizure frequency in adult patients with medically intractable extratemporal lobe epilepsy (ETLE). Seven patients with medically intractable ETLE received low-frequency rTMS at 0.9 Hz, basically two sets of 15 min stimulation per day for five days in a week, with the stimulus intensity of 90% of resting motor threshold (RMT). The number of seizures during two weeks before and after the stimulation of one week was compared. Furthermore, RMT and active motor threshold (AMT) were measured before and after rTMS for each daily session. After low-frequency rTMS of one week, the frequency of all seizure types, complex partial seizures (CPSs) and simple partial seizures was reduced by 19. seizure frequency by low-frequency rTMS has been suggested. [3] [4] [5] rTMS could have a similar mechanism of action to that of electric cortical stimulation for seizure suppression, and recently we demonstrated that electric cortical stimulation at 0.9 Hz as well as 50 Hz has suppressive effect on epileptic spikes. [6] [7] [8] A previous open study showed significant seizure reduction by 0.33 Hz rTMS in seven patients with extratemporal lobe epilepsy (ETLE) and two with temporal lobe epilepsy (TLE). 3 A case report showed 70% seizure reduction by 0.5 Hz low-frequency rTMS in a patient with intractable partial seizures due to focal cortical dysplasia in the parietal region. 4 A recent controlled study, by using 1 Hz rTMS for 15 min twice daily for one week at 120% of motor threshold (MT), showed a trend of short-term seizure decrease mainly in patients with neocortical rather than mesial temporal foci. 5 However, neither adequate parameter for stimulation nor factors for predicting the efficacy of this method have been fully established.
We aimed at accumulating data of seizure reduction by low-frequency rTMS in adult patients with ETLE, based on the hypothesis that patients with neocortical epilepsy may show better therapeutic outcome than those with TLE because of the proximity of the epileptic focus to the TMS coil in the former rather than in the latter. We also measured MT by single pulse TMS, trying to evaluate whether cortical excitability at the baseline level relate to the degree of seizure reduction. 
Methods Subjects

Repetitive transcranial magnetic stimulation (rTMS)
Low-frequency rTMS was delivered by a round coil with an intermediate diameter of 9 cm using a device of Magstim Super Rapid Magnetic Stimulator (Magstim Co., Whitland, Dyfed, UK). The center of the coil was placed at either FCz or PCz, and the electric current in the coil was either clockwise or counterclockwise, depending on the target region where the most prominent epileptic activity was documented by the long-term video EEG monitoring ( Table 1 ). The intensity of rTMS was set to 90% of the resting motor threshold (RMT) or 100% of active motor threshold (AMT) when RMT was higher than the maximum output of the stimulator. Basically, we delivered rTMS with the frequency of 0.9 Hz for 15 min, which is known to depress cortical excitability, 12 twice daily with the intermission for 5 min, 388 M. Kinoshita et al. and it was repeated for five days in a week. This procedure was partly similar to that adopted in the previous report. 5 When the patient complained of unendurable symptoms such as focal headache and muscle contraction under the coil, the stimulus intensity was reduced to 90% of AMT, and if that intensity was still intolerable, the stimulation was stopped for several minutes, and re-started after full recovery if the patient agreed. For patients 1 and 2, the 15 min session was delivered once daily.
In case convulsive seizures occurred during rTMS, we planned to judge whether they were evoked by TMS or not based on the presence of elicited jerking of the target muscle and spreading to the proximal parts. 13 Study of motor cortex excitability change RMT and AMTwere determined using the same round coil as used for low-frequency rTMS before and after stimulation on each day. Motor-evoked potential (MEP) was recorded by a pair of surface electrodes from the first dorsal interosseous muscle (FDI) contralateral to the hemisphere in which the most frequent seizure activities were observed by video EEG monitoring. The threshold intensity for MEP was expressed as a percentage of the maximum stimulator output. RMTwas defined as the lowest intensity to elicit an MEP of more than 50 mV in three out of five consecutive trials by increasing the stimulus intensity from subthreshold levels by 1%. AMT was defined as the lowest intensity to elicit an MEP of more than 200 mV in three out of five consecutive trials during the maximum voluntary tonic contraction of FDI. Averaged MT per patient over five days in the week of stimulation was used for comparison between before and after stimulation for every day. To evaluate the effect of five-day rTMS, MT values before stimulation on the first day were compared to that on the fifth day across patients. When the MT exceeded the maximum intensity of the stimulator, it was arbitrarily regarded as 100% for statistical analyses.
Seizure frequency evaluation
All patients and their families documented every seizure for two weeks each before and after the week of low-frequency rTMS. Every seizure was classified into seizure types 14 (SPSs, CPSs and generalized tonic-clonic seizures (GTC Ss)) based on the clinical observation, and the mean number of seizures per week was calculated for each seizure type. During the study period, medication was kept constant.
Statistics
For comparison between seizure frequency and MT, nonparametric methods (Wilcoxon's signed rank test and Mann-Whitney U-test) were used. Kendall's tests were employed for correlation analyses comparing the degree of seizure decrease with the mean MT across five days, which was measured before rTMS for every day for each patient. Significance level was set to p < 0.05.
Results
Effect of rTMS on seizures
Before low-frequency rTMS, the mean seizure frequency per week of all seizure types, CPSs and SPSs was 16.5 AE 5.2, 7.7 AE 1.9 and 13.6 AE 5.5 (mean AE S.E.), respectively. After low-frequency rTMS, Low-frequency rTMS in epilepsy 389 the mean seizure frequency across the patients for all seizure types, CPSs and SPSs was 13.4 AE 4.4, 4.9 AE 1.4 and 12.6 AE 5.1 (Fig. 1) , and reduction rate was 19.1%, 35.9% and 7.4%, respectively. The degree of seizure reduction did not reach statistical significance. By comparison of seizure frequency before and after rTMS, there was a tendency that rTMS was more effective for CPSs than SPSs. Four patients (patients 1-4) reported subjective improvement of seizures not only in frequency but also in duration and severity. Patient 4, who mainly had CPSs before stimulation, almost exclusively had SPSs after rTMS, and thus this patient showed the maximum reduction of CPSs by 88.5%. Patient 2 had very unpleasant aura almost continuously before rTMS, which was markedly reduced after rTMS. Two patients (patients 5 and 6) who had seizures only during sleep period showed no reduction of seizures by lowfrequency rTMS. Patient 6 had three GTC Ss during the two weeks of observation period before rTMS, and had two GTC Ss after rTMS. During rTMS, two patients (patients 2 and 6) complained of headache in the region attached to the TMS coil. No convulsive seizure was induced by TMS in this study. Patient 3 had SPSs and CPSs of the same semiology and severity as her habitual ones during stimulation, which was considered not to be evoked by rTMS. Stimulation was continued during the habitual SPSs, but stopped during CPSs, and re-started after full recovery if the patient agreed.
Effect of rTMS on MT
The patients showed relatively high RMT and AMT before rTMS (Table 2) . In patient 2, MT was not measured on the fifth day after rTMS because of headache, and thus the averaged data of the other four days was used. MT data of patient 6 were not included for the comparison between before and after rTMS, because the MT of the ipsilateral FDI was adopted as the stimulus intensity of everyday stimulation, since MT of the left FDI was lower than that of the right by TMS over left hemisphere. Neither RMT nor AMT changed after low-frequency rTMS within each day, and there was no significant change in RMT or AMT after five days of rTMS, either (Table 2 ). For any type of seizures (all seizure types, SPSs and CPSs), reduction rate was not significantly correlated with RMT or AMT. However, difference between AMT and RMT was significantly correlated with the reduction rate of CPSs (Kendall's test, p < 0.05, t = 0.733) (Fig. 2) , showing that smaller decrease of MT by voluntary muscle contraction was associated with larger reduction of CPSs. In this correlation analysis we used MT data of patient 6 obtained by the figure-of-eight coil placed on the left hemisphere.
Discussion
This pilot study showed a favorable tendency of seizure reduction in two weeks after low-frequency rTMS in medically intractable ETLE patients. The frequency of all seizure types, CPSs and SPSs reduced by 19.1, 35.9 and 7.4%, respectively. The degree of decrease in all seizure types was similar to that reported in the previous controlled study, which showed 16% reduction in all patients and 24% reduction in neocortical epilepsy patients during two weeks of post-rTMS period. 5 It is probably due to the similar stimulation parameter of 1 Hz for 15 min twice daily employed in that study. 5 Other studies with better seizure outcome employed stimulating frequency of 0.33 Hz 3 and 0.5 Hz, 4 and thus slower stimulus rate than ours would be 390 M. Kinoshita et al. more effective in order to suppress seizures in longer period. This hypothesis conflicts with the previous study that showed greater amplitude reduction of MEP by rTMS at 0.9 Hz than 0.1 Hz, 12 but supports their description that the spread of excitation and changes of MEP amplitude are possibly independent phenomena. 12 However, data obtained from healthy subjects cannot be directly adopted, since patients had seizure and were treated by antiepileptic drugs that can modify the effect of low-frequency rTMS.
It is noteworthy, although not statistically significant, that the overall mean reduction of CPSs frequency across the patients was 35.9% in the present study, and the maximum reduction rate of CPSs per patient was 88.5%. A relatively high effectiveness of low-frequency rTMS to CPSs than to SPSs contradicts the common notion that SPSs is a milder or more fragmented seizure than CPSs. One possible explanation for this phenomenon is that low-frequency rTMS is sufficiently effective enough to suppress the seizure spread, but is not so sufficient as to suppress epileptic activities at the seizure foci. The suppression of seizure spread may be related to the enhancement of surround inhibition, as demonstrated by a prolonged inhibitory synaptic potential at the cellular level. 15 The present study showed relatively high MT in epilepsy patients, all of whom were treated by sodium channel blockers (carbamazepine and/or phenytoin) known to increase MT. 16, 17 Because of the small patient population of this study, we could not further evaluate the effect of each antiepileptic drug on MT or on the clinical efficacy of low-frequency rTMS. The present study did not show any changes in RMTor AMT by low-frequency rTMS, when compared between before and after stimulation of either each day or across five days, possibly because motor cortex was not directly stimulated. However, considering previous reports in which inhibition of ipsilateral motor cortex after subthreshold low-frequency rTMS on premotor cortex were demonstrated by reduction of MEP size, 18 task-related EEG power and EEG-EMG coherence, 19 the present observation may suggest that low-frequency rTMS have little effect upon the neuronal membrane excitability. 16 The present study also showed that the difference between AMT and RMT correlated significantly to the reduction rate of CPSs, that is, the smaller the difference between RMT and AMT, the more effective was rTMS. The reduction of MT by voluntary tonic contraction is related to increased excitability of corticospinal neurons 20 and spinal motoneurons, 21 and basically RMT and AMT behave similarly as demonstrated in the pharmacological challenge in healthy subjects. 16 Patients with larger reduction of MT by voluntary muscle contraction may still have significant capacity to increase excitability in this motor system despite antiepileptic medication, which may result in insufficient seizure reduction by low-frequency rTMS. We used the maximum voluntary muscle contraction to determine AMT because fine control of the degree of muscle strength was difficult for patients, while usually 20% of the maximum muscle force is used to define AMT. The condition of AMT in the present study may have led to a greater difference between AMT and RMT, enabling us to demonstrate significant correlation.
Other parameters indicating intracortical inhibition by means of paired pulse stimulation may demonstrate further information. In summary, this was the first pilot study to test the therapeutic effect of rTMS in a patient group consisting exclusively of ETLE and to evaluate the relationship between the therapeutic outcome of rTMS and cortical excitability as shown by RMT and AMT. A favorable tendency of seizure reduction was shown, though not statistically significant, in two weeks after low-frequency rTMS in medically intractable ETLE patients, especially those of CPSs, possibly through a suppressive effect on seizure spread. For the practical use of low-frequency rTMS for seizure reduction, larger studies are needed to investigate better stimulation parameters, prognostic factors and interaction with medication.
